7 Medications for Neurological Conditions
Compare medication roles, treatment goals, and important safety considerations for Parkinson disease, Alzheimer disease, migraine, and multiple sclerosis.
Parkinson disease medicines
enters the brain and is converted to dopamine, helping manage movement symptoms of Parkinson disease. It does not stop the disease from progressing.
reduces breakdown outside the brain. As a result, more can reach the brain, and some peripheral effects can be reduced. This is why is commonly combined with .
Parkinson medicines should not be changed or stopped without medical advice. Sudden discontinuation of – can have serious consequences, so a person should consult their prescriber before changing or stopping it.
Alzheimer disease medicines
is a cholinesterase inhibitor that slows the breakdown of acetylcholine and may help manage cognitive symptoms. Cholinesterase inhibitors are symptomatic treatments: does not cure Alzheimer disease.
Lecanemab and donanemab target beta-amyloid and are used for eligible people with early Alzheimer disease. An important safety consideration is , which can involve swelling or bleeding in the brain. MRI monitoring is important when using these medicines.
Acute and
Migraine medicines can serve different purposes: some treat an attack that is happening, while others aim to reduce future attacks. Triptans, such as sumatriptan, are acute medicines that can help relieve an attack underway.
may include medicines such as topiramate, certain beta-blockers, anticonvulsants, or CGRP-targeting therapies. The appropriate choice depends on the individual’s health and migraine pattern. Preventive medicines are distinct from acute medicines used to relieve an ongoing attack.
Multiple sclerosis treatment goals
target multiple sclerosis disease activity. They may reduce inflammatory activity, including relapses, help limit future disease activity, and may delay disability progression. They do not reverse all existing nerve damage or treat every MS symptom with one medicine. The specific treatment depends on the type of MS and individual factors.
, such as methylprednisolone, may be used during an MS relapse to speed recovery from an attack. They do not alter the disease’s long-term course and have a different role from long-term DMTs.
Matching medicines to treatment goals
Medication roles depend on both the condition and the treatment phase. Some medicines manage symptoms or an attack that is underway; others aim to reduce future disease activity. Treatment choices depend on the person’s condition and require clinician guidance.